Royal Bank of Canada
SSKN

Royal Bank of Canada’s Strata Skin Sciences SSKN Stock Holding History

Royal Bank of Canada’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39
Closed – – 7409
2024
Q2 		$0 Buy
39
+16
+70% +$65 ﹤0.01% 7509
2024
Q1 		$0 Sell
23
-9
-28% -$47 ﹤0.01% 7559
2023
Q4 		$0 Buy
32
+27
+540% +$140 ﹤0.01% 7557
2023
Q3 		$0 Sell
5
-22
-81% -$169 ﹤0.01% 7559
2023
Q2 		$0 Buy
+27
New +$266 ﹤0.01% 7647
2023
Q1 		– Hold
0
– – – 7454
2022
Q4 		– Sell
-16
Closed – – 7689
2022
Q3 		$0 Buy
+16
New +$162 ﹤0.01% 7838
2020
Q4 		– Sell
-1
Closed – – 7274
2020
Q3 		$0 Buy
+1
New +$14 ﹤0.01% 6914
2019
Q2 		– Sell
-1
Closed – – 7154
2019
Q1 		$0 Buy
+1
New +$30 ﹤0.01% 7081
2018
Q2 		– Hold
0
– – – 6750
2018
Q1 		– Sell
-1
Closed -$13 – 6759
2017
Q4 		$0 Buy
+1
New +$14 ﹤0.01% 6858
2017
Q3 		– Hold
0
– – – 6961

Other funds holding SSKN

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $1.13B AUM 38.47% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada's SSKN Position: Q3 2024 in Review

Royal Bank of Canada sold out of Strata Skin Sciences (SSKN) in Q3 2024, closing a stake of 39 shares.

Royal Bank of Canada first reported a position in SSKN in Q4 2017 and held it in 9 quarters. The position peaked at $0 in Q2 2024. 19 funds tracked by Wall St. Rank hold SSKN as of Q3 2024.

  • Royal Bank of Canada reported no remaining Strata Skin Sciences position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 39 Strata Skin Sciences shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Strata Skin Sciences in Q4 2017 and held it in 9 quarters.
  • Royal Bank of Canada's Strata Skin Sciences position peaked at $0 in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.